Phase 2 Recurrent Ovarian Cancer Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
Recurrent Ovarian CancerFolate Receptor-Alpha Positive
AbbVie100 enrolled40 locationsNCT06365853
Recruiting
Phase 1Phase 2
Combination Therapy for Recurrent Ovarian Cancer
Recurrent Ovarian Cancer
Sham Sunder Kakar72 enrolled1 locationNCT05610735
Recruiting
Phase 2
QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer
Treatment of Recurrent Ovarian Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University40 enrolled1 locationNCT07286240
Recruiting
Phase 1Phase 2
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Endometrial CancerRecurrent Ovarian CancerRecurrent Fallopian Tube Cancer+2 more
Regeneron Pharmaceuticals890 enrolled51 locationsNCT03564340
Recruiting
Phase 2
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
Recurrent Ovarian Cancer
Akeso172 enrolled1 locationNCT06560112
Recruiting
Phase 2
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Platinum-resistant Recurrent Ovarian Cancer
Shanghai Jiaolian Drug Research and Development Co., Ltd90 enrolled17 locationsNCT06434610
Recruiting
Phase 2Phase 3
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER
Recurrent Ovarian CancerSignal Transduction Pathway DeregulationTherapy-Associated Cancer
Gynaecologisch Oncologisch Centrum Zuid148 enrolled6 locationsNCT03458221
Not Yet Recruiting
Phase 2
Immune regulation and timing of chemotherapy in advanced/recurrent ovarian cancer to evaluate tumour response
Recurrent Ovarian Cancer
Royal Women's Hospital37 enrolled1 locationACTRN12608000013369